Stock Research for CYTX


Featured Broker: Ally Invest

Get the due diligence for another stock.


CYTX Stock Chart & Research Data

The CYTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CYTX Due diligence Resources & Stock Charts

The CYTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CYTX Detailed Price Forecast - CNN Money CNN View CYTX Detailed Summary - Google Finance
Yahoo View CYTX Detailed Summary - Yahoo! Finance Zacks View CYTX Stock Research & Analysis -

Stock Analysis

TradeIdeas View CYTX Trends & Analysis - Trade-Ideas Barrons View CYTX Major Holders - Barrons
NASDAQ View CYTX Call Transcripts - NASDAQ Seeking View CYTX Breaking News & Analysis - Seeking Alpha
Spotlight View CYTX Annual Report - OTC Report View CYTX OTC Short Report -
TradeKing View CYTX Fundamentals - TradeKing Charts View CYTX SEC Filings - Bar Chart
WSJ View Historical Prices for CYTX - The WSJ Morningstar View Performance/Total Return for CYTX - Morningstar
MarketWatch View the Analyst Estimates for CYTX - MarketWatch CNBC View the Earnings History for CYTX - CNBC
StockMarketWatch View the CYTX Earnings - StockMarketWatch MacroAxis View CYTX Buy or Sell Recommendations - MacroAxis
Bullish View the CYTX Bullish Patterns - American Bulls Short Pains View CYTX Short Pain Metrics -

Social Media Mentions

StockTwits View CYTX Stock Mentions - StockTwits PennyStocks View CYTX Stock Mentions - PennyStockTweets
Twitter View CYTX Stock Mentions - Twitter Invest Hub View CYTX Investment Forum News - Investor Hub
Yahoo View CYTX Stock Mentions - Yahoo! Message Board Seeking Alpha View CYTX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CYTX - Insider Cow View Insider Transactions for CYTX - Insider Cow
CNBC View CYTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CYTX - OTC Markets
Yahoo View Insider Transactions for CYTX - Yahoo! Finance NASDAQ View Institutional Holdings for CYTX - NASDAQ

Stock Charts

FinViz View CYTX Stock Insight & Charts - StockCharts View CYTX Investment Charts -
BarChart View CYTX Stock Overview & Charts - BarChart Trading View View CYTX User Generated Charts - Trading View

Latest Financial News for CYTX

Cytori Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering
Posted on Tuesday June 12, 2018

Cytori Therapeutics, Inc. (CYTX) ("Cytori"), today provided an informational update to stockholders regarding its proposed rights offering and the expected key dates and terms relative to the offering. Stockholders are advised to ensure they complete their open market purchases of Cytori common stock by Friday, June 22, 2018 to be considered a stockholder of record on Tuesday, June 26, 2018.  Stockholders or interested parties are advised to direct all questions and informational requests to the contacts listed below. Under the proposed rights offering, Cytori will distribute one non-transferable subscription right for each share of common stock and Series B Convertible Preferred Stock (on an as-if-converted-to-common-stock basis) held on the record date.  Each right will entitle the holder to purchase one unit, at a subscription price of $1,000 per unit, consisting of one share of Series C Convertible Preferred Stock with a face value of $1,000 (and immediately convertible into shares of Cytori’s common stock at a conversion price of $2.64 per share) and 200 warrants to purchase Cytori’s common stock with an exercise price of $3.17 per share.  The warrants will be exercisable for 30 months after the date of issuance.

Cytori Therapeutics Inc (NASDAQ:CYTX): Are Analysts Optimistic?
Posted on Friday May 25, 2018

Cytori Therapeutics Inc’s (NASDAQ:CYTX): Cytori Therapeutics, Inc., a therapeutics company, together with its subsidiaries, develops regenerative and oncologic therapies from its proprietary cell therapy and nanoparticle platforms for various medicalRead More...

Benzinga's Daily Biotech Pulse: Eiger And Melinta Fall On Offerings, Apellis And Marinus Rise On Bullish Ratings
Posted on Thursday May 24, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 23) ABIOMED, Inc. (NASDAQ: ABMD ) ArQule, Inc. (NASDAQ: ARQL ) Crispr ...

Cytori Therapeutic’s common stock to begin trading on adjusted basis on May 24, following one-for-ten reverse split
Posted on Wednesday May 23, 2018

Cytori Therapeutics (CYTX) (“Cytori” or the “Company”) today announced that the Company effected a reverse stock split that became effective on May 23, 2018 at a ratio of one-for-ten, and that the Company’s common stock will commence trading on a post-split basis beginning on May 24, 2018. The Company received the requisite stockholder approval for the reverse stock split on May 18, 2018. The new CUSIP number for the Company’s common stock will be 23283K402.

Enter a stock symbol to view the stock details.